创新药板块走弱 荣昌生物跌超7%

Group 1 - The innovative drug sector is experiencing a downturn, with Rongchang Biologics falling over 7% [1] - Other companies such as Rundu Co., Ltd. (002923), Rejing Biologics, Warner Pharmaceuticals, and Wanbang Medicine (301520) also saw declines [1] - There is a disclosure of dark pool fund flows, indicating signals for early detection of stock accumulation by major investors [1]